Pharmacologically active compounds
    9.
    发明授权
    Pharmacologically active compounds 失效
    药理活性化合物

    公开(公告)号:US4301165A

    公开(公告)日:1981-11-17

    申请号:US70950

    申请日:1979-08-30

    CPC classification number: C07D233/64

    Abstract: The compounds are C.sub.2 -C.sub.8 straight chain alkanes terminally substituted symmetrically or unsymmetrically, by N-(N'-substituted guanidino), N-(N',N"-disubstituted guanidino), N-(N'-substituted thioureido), N-(nitromethylene amidino) or S-(N-substituted isothioureido) groups. Two compounds of the invention are 1,3-bis-[N'-(2-(5-methyl-4-imidazolylmethylthio)ethyl)guanidino]propane and 1,3-bis-[S-(N-2-(5-methyl-4-imidazolylmethylthio)ethyl)isothioureido]propane. The compounds of this invention are inhibitors of H-2 histamine receptors.

    Abstract translation: 这些化合物是由N-(N' - 取代胍基),N-(N',N“ - 二取代胍基),N-(N' - 取代的硫脲基),对称或不对称的末端取代的C 2 -C 8直链烷烃, N-(硝基亚甲基脒基)或S-(N-取代的异硫脲基)基团。 本发明的两种化合物是1,3-双 - [N' - (2-(5-甲基-4-咪唑基甲硫基)乙基)胍基]丙烷和1,3-双 - [S-(N-2-(5 - 甲基-4-咪唑基甲硫基)乙基)异硫脲基]庚烷。 本发明的化合物是H-2组胺受体的抑制剂。

Patent Agency Ranking